149 related articles for article (PubMed ID: 36240948)
1. Cannabidiol inhibits microglia activation and mitigates neuronal damage induced by kainate in an in-vitro seizure model.
Landucci E; Mazzantini C; Lana D; Calvani M; Magni G; Giovannini MG; Pellegrini-Giampietro DE
Neurobiol Dis; 2022 Nov; 174():105895. PubMed ID: 36240948
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective Effects of Cannabidiol but Not Δ
Landucci E; Mazzantini C; Lana D; Davolio PL; Giovannini MG; Pellegrini-Giampietro DE
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575932
[TBL] [Abstract][Full Text] [Related]
3. The Protective Effect of CBD in a Model of In Vitro Ischemia May Be Mediated by Agonism on TRPV2 Channel and Microglia Activation.
Lana D; Landucci E; Mazzantini C; Magni G; Pellegrini-Giampietro DE; Giovannini MG
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292998
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Administration of Cannabidiol Reduces Microglial Inflammatory Response to Kainate-Induced Seizures and Neurogenesis.
Victor TR; Hage Z; Tsirka SE
Neuroscience; 2022 Sep; 500():1-11. PubMed ID: 35700815
[TBL] [Abstract][Full Text] [Related]
5. Cannabis constituents reduce seizure behavior in chemically-induced and scn1a-mutant zebrafish.
Thornton C; Dickson KE; Carty DR; Ashpole NM; Willett KL
Epilepsy Behav; 2020 Sep; 110():107152. PubMed ID: 32585475
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.
Hampson AJ; Grimaldi M; Axelrod J; Wink D
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8268-73. PubMed ID: 9653176
[TBL] [Abstract][Full Text] [Related]
7. Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se.
Hill AJ; Jones NA; Smith I; Hill CL; Williams CM; Stephens GJ; Whalley BJ
Neurosci Lett; 2014 Apr; 566():269-74. PubMed ID: 24642454
[TBL] [Abstract][Full Text] [Related]
8. Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells.
Juknat A; Pietr M; Kozela E; Rimmerman N; Levy R; Coppola G; Geschwind D; Vogel Z
Br J Pharmacol; 2012 Apr; 165(8):2512-28. PubMed ID: 21542829
[TBL] [Abstract][Full Text] [Related]
9. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
Szaflarski JP; Bebin EM
Epilepsy Behav; 2014 Dec; 41():277-82. PubMed ID: 25282526
[TBL] [Abstract][Full Text] [Related]
10. Source of cannabinoids: what is available, what is used, and where does it come from?
Specchio N; Pietrafusa N; Cross HJ
Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
[TBL] [Abstract][Full Text] [Related]
11. Partial protective effects of cannabidiol against PTZ-induced acute seizures in female rats during the proestrus-estrus transition.
Janisset NRLL; Romariz SAA; Hashiguchi D; Quintella ML; Gimenes C; Yokoyama T; Filev R; Carlini E; Barbosa da Silva R; Faber J; Longo BM
Epilepsy Behav; 2022 Apr; 129():108615. PubMed ID: 35217387
[TBL] [Abstract][Full Text] [Related]
12. Neuronal and Astrocytic Morphological Alterations Driven by Prolonged Exposure with Δ9-Tetrahydrocannabinol but Not Cannabidiol.
Landucci E; Mazzantini C; Lana D; Giovannini MG; Pellegrini-Giampietro DE
Toxics; 2022 Jan; 10(2):. PubMed ID: 35202235
[TBL] [Abstract][Full Text] [Related]
13. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
14. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
[TBL] [Abstract][Full Text] [Related]
15. Cannabis for the Treatment of Epilepsy: an Update.
Gaston TE; Szaflarski JP
Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of Medical Cannabis.
Amin MR; Ali DW
Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Rosenberg EC; Patra PH; Whalley BJ
Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
[TBL] [Abstract][Full Text] [Related]
18. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
[TBL] [Abstract][Full Text] [Related]
19. A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT
Echeverry C; Prunell G; Narbondo C; de Medina VS; Nadal X; Reyes-Parada M; Scorza C
Neurotox Res; 2021 Apr; 39(2):335-348. PubMed ID: 32886342
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP).
Klein BD; Jacobson CA; Metcalf CS; Smith MD; Wilcox KS; Hampson AJ; Kehne JH
Neurochem Res; 2017 Jul; 42(7):1939-1948. PubMed ID: 28478594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]